Literature DB >> 6125186

The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

B N Prichard, R J Walden.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6125186      PMCID: PMC1402177          DOI: 10.1111/j.1365-2125.1982.tb01938.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  38 in total

1.  Abrupt propranolol withdrawal and myocardial contractility. A study of effects in normal man.

Authors:  J A Pantano; Y C Lee
Journal:  Arch Intern Med       Date:  1976-08

2.  Acute coronary syndromes following abrupt cessation of oral propranolol therapy.

Authors:  H F Mizgala; J Counsell
Journal:  Can Med Assoc J       Date:  1976-06-19       Impact factor: 8.262

3.  Withdrawal of propranolol and myocardial infarction.

Authors:  R Slome
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

4.  Myocardial infarction after propranolol withdrawal.

Authors:  R G Diaz; J Somberg; E Freeman; B Levitt
Journal:  Am Heart J       Date:  1974-08       Impact factor: 4.749

5.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

6.  Coronary artery syndromes after sudden propranolol withdrawal.

Authors:  E L Alderman; D J Coltart; G E Wettach; D C Harrison
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

7.  Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.

Authors:  B N Prichard; P M Gillam
Journal:  Br Heart J       Date:  1971-07

8.  Propranolol in angina pectoris.

Authors:  T T Zsotér; D S Beanlands
Journal:  Arch Intern Med       Date:  1969-11

9.  Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

Authors:  E F Ellis; O Oelz; L J Roberts; N A Payne; B J Sweetman; A S Nies; J A Oates
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

10.  Trasicor in angina pectoris: a double-blind trial.

Authors:  D F Wilson; O F Watson; J S Peel; A S Turner
Journal:  Br Med J       Date:  1969-04-19
View more
  12 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 2.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  Treatment of endocrine diseases.

Authors:  W M Hague
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

4.  The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.

Authors:  R J Walden; P Bhattacharjee; B Tomlinson; J Cashin; B R Graham; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 5.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

6.  The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.

Authors:  K S Kiyingi; J Shaw
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Patients compliance in hypertension--the importance of number of tablets.

Authors:  J Asplund; M Danielson; P Ohman
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

9.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.

Authors:  Martina Teichert; Peter A G M de Smet; Albert Hofman; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.